光療法市場 (2026 - 2035)

The secondary research process involved comprehensive analysis of medical device regulatory databases, peer-reviewed dermatology and psychiatric journals, clinical phototherapy publications, and authoritative health organizations. Key sources included the US Food & Drug Administration (FDA) 510(k) clearances for light therapy devices, European Medicines Agency (EMA) medical device regulations, International Organization for Standardization (ISO) 13485 medical device quality management certifications, and the International Electrotechnical Commission (IEC) 60601-1 safety standards for light therapy equipment. Clinical and epidemiological data were gathered from the National Institutes of Health (NIH), National Center for Biotechnology Information (NCBI/PubMed), and the Cochrane Library for systematic reviews on phototherapy efficacy.

Dermatology-specific sources included the American Academy of Dermatology (AAD), European Academy of Dermatology and Venereology (EADV), International Psoriasis Council, National Psoriasis Foundation, and the American Society for Photobiology. Mental health and sleep disorder statistics were sourced from the National Institute of Mental Health (NIMH), American Psychiatric Association (APA), National Sleep Foundation, European Sleep Research Society, and the Centers for Disease Control and Prevention (CDC) National Center for Health Statistics. Global health data incorporated the World Health Organization (WHO) Global Health Observatory, EU Eurostat Health Database, OECD Health Statistics, and national health ministry reports from key markets including the UK NHS Digital, German Federal Institute for Drugs and Medical Devices (BfArM), and Japan's Ministry of Health, Labour and Welfare (MHLW). These sources were utilized to collect prevalence data for seasonal affective disorder (SAD), psoriasis, acne vulgaris, and sleep disorders; regulatory approval pathways for LED and UV phototherapy devices; clinical safety studies; reimbursement policies; and competitive landscape analysis across blue light, red light, and white light therapy technologies.

To gather qualitative and quantitative information unique to phototherapy equipment and light-based wellness products, supply-side and demand-side stakeholders were interviewed during the primary research process. Executives from medical device OEMs, innovation leads from wellness technology businesses, and CEOs, VPs of Product Development, heads of regulatory affairs, and commercial directors from companies that provide light therapy lamps, light boxes, and handheld LED devices were among the supply-side sources. Board-certified dermatologists with expertise in phototherapy, psychiatrists who treat depression and seasonal affective disorder, sleep medicine specialists, medical spa directors, procurement leads from hospital phototherapy departments and dermatology clinics, and distributors of light therapy equipment for home use were among the demand-side sources. Primary research confirmed product pipeline timelines for multi-wavelength and smart-connected devices, validated market segmentation across product categories (light boxes vs. handheld devices vs. dawn simulators), and collected information on clinical adoption patterns for blue light acne treatment versus white light SAD therapy, pricing strategies for prescription versus over-the-counter devices, and reimbursement dynamics for clinical phototherapy versus wellness applications.

Primary Respondent Breakdown:

By Designation: C-level Primaries (30%), Director Level (35%), Others (35%)

By Region: North America (32%), Europe (30%), Asia-Pacific (28%), Rest of World (10%)

Global market valuation was derived through revenue mapping, device unit shipment analysis, and procedure volume estimation for clinical phototherapy sessions. The methodology included:

Identification of 40+ key manufacturers across North America, Europe, Asia-Pacific, and Latin America specializing in light therapy boxes, dawn simulators, handheld LED devices, and light visors

Product mapping across blue light (acne/psoriasis), red light (anti-aging/wound healing), white light (SAD/circadian rhythm), and multi-spectrum LED categories

Analysis of reported and modeled annual revenues specific to light therapy device portfolios, including both medical-grade and consumer wellness segments

Coverage of manufacturers representing 72-76% of global market share in 2024, encompassing major players in professional phototherapy equipment and home-use light therapy lamps

Extrapolation using bottom-up (device shipments × ASP by country/region, procedure volumes for in-clinic phototherapy) and top-down (manufacturer revenue validation, distributor markup analysis) approaches to derive segment-specific valuations for light boxes, floor/desk lamps, handheld devices, light visors, and dawn simulators across dermatology, psychiatric, and sleep disorder applications